Login
Walgreens Boots Alliance NASDAQ: WBA
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
| Name | Walgreens Boots Alliance |
| Ticker | WBA |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Healthcare Supply Chain & InfoTech |
|
Price
52W Low/High |
46.53
33.52 / 56.80 |
| Momentum | Weak Down |
| Market cap | 40 B |
| 1Y Total Return |
18.32 %
Below Average |
| 1Y Volatility |
33.17 %
Average Risk |
Relative Strength Index : Attempt to identify overbought (above 80) and oversold (below 20) conditions
Walgreens Boots Alliance, Inc. operates as a pharmacy-led health and wellbeing company
Details
| Ticker | WBA |
| Name | Walgreens Boots Alliance |
| ISIN | US9314271084 |
| CUSIP | 931427108 |
| Exchange | NASDAQ |
| Sector | Health Care |
| Industry | Healthcare Supply Chain & InfoTech |
| Country | USA |
| Currency | U.S. Dollar |
| In Index(ices) | Nasdaq 100 Index |
Share as of 07/23/2021
| Close Price | 46.53 |
| 52W Low/High | 33.52 / 56.80 |
| Market cap | 40 B |
| 1Y Total Return |
18.32 %
Below Average |
| 1Y Volatility |
33.17 %
Average Risk |
| Beta | 0.88 |
| PE (trailing) |
17.62
Below Average |
| 12M Dividends | 1.87 |
| Last Dividend Date | 02/18/2021 |
| Dividend Yield | 4.02 % |
Fin. Strength
| Net Profit Margin | 1.7 % |
| Cash from Op. / Cur. Liabilities | 0.19 |
| Diluted Earnings / Share | 2.64 |
| ROE | 10.7 % |
| ROIC | 4.2 % |
| Price / Revenue | 0.3 |
| Price / Book | 1.8 |
| Price / CF | 6.3 |
| Current Ratio | 0.8 |
| Cur.Liabilities / Tot.Liabilities | 0.5 |
| Financial Leverage | 1.81 |
| in Mils USD |
rolling-year up to June
|
||||||
|---|---|---|---|---|---|---|---|
| Income Statement | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Revenue |
137,862
|
134,260
|
136,354
|
128,244
|
116,701
|
117,237
|
|
| Gross Profit |
27,876
|
27,945
|
30,424
|
30,557
|
28,977
|
29,813
|
|
| R&D |
0
|
0
|
0
|
0
|
0
|
0
|
|
| EBITDA |
5,499
|
3,552
|
8,207
|
7,639
|
7,509
|
6,324
|
|
| Operating Income |
3,655
|
1,265
|
5,674
|
5,994
|
5,566
|
5,201
|
|
| Net Income exc. Extra |
2,288
|
760
|
4,816
|
4,314
|
4,306
|
3,169
|
|
| per Share | |||||||
| Diluted avg Shares |
867
|
875
|
911
|
995
|
1,083
|
1,088
|
|
| EPS exc. Extra |
2.64
|
0.83
|
5.09
|
4.28
|
3.96
|
2.83
|
|
| Dividend |
1.87
|
1.83
|
1.76
|
1.60
|
1.50
|
1.44
|
|
| Div. Yield (an.) |
3.55 %
|
4.26 %
|
3.57 %
|
2.56 %
|
1.85 %
|
1.86 %
|
|
| Balance Sheet | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Total Assets |
91,920
|
86,444
|
68,586
|
70,152
|
74,173
|
67,333
|
|
| Cash, Eq & Invt ShortTerm |
1,345
|
768
|
839
|
1,818
|
12,253
|
3,291
|
|
| Total Current Assets |
26,607
|
18,326
|
19,021
|
19,988
|
28,152
|
19,713
|
|
| Total Non-Current Assets |
65,313
|
68,118
|
49,565
|
50,164
|
46,021
|
47,620
|
|
| Intangibles |
22,928
|
25,131
|
28,042
|
29,200
|
25,724
|
27,658
|
|
| Total Liabilities |
69,014
|
65,121
|
43,815
|
41,682
|
42,689
|
36,019
|
|
| Total Current Liabilities |
34,475
|
26,649
|
25,060
|
21,482
|
21,713
|
15,811
|
|
| Long Term Debt |
34,539
|
38,472
|
18,755
|
20,200
|
20,976
|
20,208
|
|
| Shareholder equity |
22,101
|
20,736
|
24,133
|
27,736
|
30,600
|
30,881
|
|
| Cash Flow | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Cash from Operations |
6,396
|
5,777
|
6,032
|
7,464
|
7,895
|
6,694
|
|
| Depreciation |
1,935
|
1,973
|
1,982
|
1,710
|
1,691
|
1,749
|
|
| Cash from Investing |
-1,978
|
-1,398
|
-1,959
|
-5,502
|
-2,008
|
-2,353
|
|
| Capex |
1,413
|
1,418
|
1,630
|
1,422
|
1,333
|
1,265
|
|
| Cash from Financing |
-3,505
|
-4,472
|
-5,085
|
-12,384
|
3,167
|
-5,431
|
|
| Stock Issued |
-269
|
-1,750
|
-6,217
|
-6,127
|
-1,223
|
-1,269
|
|
| Debt (LT) Issued |
2,357
|
-1,089
|
2,722
|
-4,268
|
6,155
|
-2,548
|
|
| Free Cash Flow |
13,248
|
4,314
|
10,219
|
13,281
|
2,279
|
5,486
|
|
| Ratios | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
| Net Profit Margin |
1.7 %
|
0.6 %
|
3.5 %
|
3.4 %
|
3.7 %
|
2.7 %
|
|
| NCFO / Op.Income |
175.0 %
|
456.7 %
|
106.3 %
|
124.5 %
|
141.8 %
|
128.7 %
|
|
| Current Ratio |
0.8
|
0.7
|
0.8
|
0.9
|
1.3
|
1.2
|
|
| Financial Leverage D/E |
1.81
|
1.96
|
0.73
|
0.54
|
0.63
|
0.44
|
|
| Return on Capital Avg |
4.2 %
|
3.0 %
|
12.0 %
|
11.1 %
|
10.3 %
|
8.1 %
|
|
| Return on Shareholder Equity |
10.7 %
|
3.4 %
|
18.6 %
|
14.8 %
|
14.0 %
|
10.1 %
|
|
Fundamentals
No documents are available for the moment, please check back soon, or save the asset to be notified when documents are available